Evidence map›Paper›PMID 33922986›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Design and Fabrication of a Triple-Band Terahertz Metamaterial Absorber.

Jinfeng Wang, Tingting Lang, Zhi Hong, Meiyu Xiao, Jing Yu

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jinfeng WangInstitute of Optoelectronic Technology, China Jiliang University, Hangzhou 310018, China.
Tingting LangInstitute of Optoelectronic Technology, China Jiliang University, Hangzhou 310018, China.
Zhi HongCentre for THz Research, China Jiliang University, Hangzhou 310018, China.ORCID 0000-0001-8995-4780
Meiyu XiaoInstitute of Optoelectronic Technology, China Jiliang University, Hangzhou 310018, China.
Jing YuInstitute of Optoelectronic Technology, China Jiliang University, Hangzhou 310018, China.

Funding

National Natural Science Foundation of China 61875179National Natural Science Foundation of China 61875251
6 · The paper itself

Abstract

We presented and manufactured a triple-band terahertz (THz) metamaterial absorber with three concentric square ring metallic resonators, a polyethylene terephthalate (PET) layer, and a metallic substrate. The simulation results demonstrate that the absorptivity of 99.5%, 86.4%, and 98.4% can be achieved at resonant frequency of 0.337, 0.496, and 0.718 THz, respectively. The experimental results show three distinct absorption peaks at 0.366, 0.512, and 0.751 THz, which is mostly agreement with the simulation. We analyzed the absorption mechanism from the distribution of electric and magnetic fields. The sensitivity of the three peaks of this triple-band absorber to the surrounding is 72, 103.5, 139.5 GHz/RIU, respectively. In addition, the absorber is polarization insensitive because of the symmetric configuration. The absorber can simultaneously exhibit high absorption effect at incident angles up to 60° for transverse electric (TE) polarization and 70° for transverse magnetic (TM) polarization. This presented terahertz metamaterial absorber with a triple-band absorption and easy fabrication can find important applications in biological sensing, THz imaging, filter and optical communication.

Indexed as

a triple-bandelectric and magnetic fieldsmetamaterial absorberpolarization independent

Identifiers

PMID33922986
PMCPMC8146610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.